home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
The Arsenal Files 6
/
The Arsenal Files 6 (Arsenal Computer).ISO
/
health
/
med9604b.zip
/
M9640723.TXT
< prev
next >
Wrap
Text File
|
1996-03-04
|
2KB
|
33 lines
Document 0723
DOCN M9640723
TI Effect of injection of anti-CD4 and anti-CD8 monoclonal antibodies on
the development of experimental systemic lupus erythematosus in mice.
DT 9604
AU Ruiz PJ; Zinger H; Mozes E; Department of Chemical Immunology, Weizmann
Institute of Science,; Rehovot, Israel.
SO Cell Immunol. 1996 Jan 10;167(1):30-7. Unique Identifier : AIDSLINE
MED/96139348
AB Induction of an experimental disease resembling systemic lupus
erythematosus (SLE) has been achieved in mice by immunization with a
human monoclonal anti-DNA antibody, bearing a common idiotype,
designated 16/6 Id. In the present study we used anti-CD4 and anti-CD8
antibodies to modulate the induction and development of the experimental
disease. Thus, depletion of CD4+ T cells prior to the immunization with
the 16/6 inhibited the induction of experimental SLE. In contrast,
injection of anti-CD4 antibodies to mice that were already immunized
with the 16/6 Id did not prevent the development of the disease.
Furthermore, administration of anti-CD8 antibodies either before or
after priming with the 16/6 Id increased the serological and clinical
manifestations of the disease. These results demonstrate the pathogenic
role of CD4+ and CD8+ T cells in the induction and development of the
experimental SLE.
DE Animal Antibodies, Monoclonal/*IMMUNOLOGY CD4-Positive
T-Lymphocytes/*PHYSIOLOGY CD8-Positive T-Lymphocytes/*PHYSIOLOGY Human
Immunization Lupus Erythematosus, Systemic/*ETIOLOGY Lymphocyte
Depletion Mice Mice, Inbred C3H Rats Support, Non-U.S. Gov't
Support, U.S. Gov't, Non-P.H.S. JOURNAL ARTICLE
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).